Although GLP-1 reportedly increases insulin secretion and suppresses glucagon secretion [23], the results of the present study demonstrated that despite the reduction of hyperglycemia, systemic administration of liraglutide had no effects on plasma insulin and glucagon levels in KKAy mice. The gene discussed is INS; the disease is Hyperglycemia.